Endobronchial Ultrasound Biopsy Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Endobronchial Ultrasound Biopsy Market Report is Segmented by Product (Biopsy Forceps, Cytology Brushes, Biopsy Needles, Transbronchial Aspiration Needles, Spray Catheters, and Other Products), Application (Cancer Diagnosis, Infection Diagnosis, and Other Applications) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (USD) for the Above Segments.

Endobronchial Ultrasound Biopsy Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Endobronchial Ultrasound Biopsy Market Size

Endobronchial Ultrasound Biopsy Market Summary
Study Period 2021 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 4.36 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Endobronchial Ultrasound Biopsy Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Endobronchial Ultrasound Biopsy Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Endobronchial Ultrasound Biopsy Market Analysis

The Endobronchial Ultrasound Biopsy Market is expected to register a CAGR of 4.36% during the forecast period.

Respiratory disorders such as chronic obstructive pulmonary disorder (COPD), tuberculosis, and lung and bronchus cancer use endobronchial ultrasound biopsy to obtain tissue or fluid samples from the lungs and surrounding lymph nodes without conventional surgery to diagnose and detect the severity of diseases. For instance, according to 2024 statistics published by the American Lung Association, an estimated 11.7 million, or 4.6% of the adult population, in the United States were given a COPD diagnosis in 2022. This translates to a large patient pool potentially requiring diagnosis. Similarly, according to the Australian Bureau of Statistics 2022 update, adults aged 65 years and above are significantly more likely to have COPD, with roughly one in fourteen (7.0%) being diagnosed. Therefore, the rising prevalence of respiratory disorders is a potential driver for the endobronchial ultrasound biopsy market.

Additionally, while smoking is the leading cause of COPD, particularly in high-income countries, household air pollution is another significant risk factor in low- and middle-income countries (LMICs). This is especially concerning as smoking rates are on the rise in LMICs, suggesting a potential explosion of COPD cases in the coming decades. As the global COPD burden grows, particularly in LMICs, the demand for accurate and early diagnosis tools like EBUS is expected to rise in the near future. This overall growth in respiratory illnesses is likely to drive up the demand for accurate and minimally invasive diagnostic tools like EBUS during the forecast period.

Furthermore, according to the World Health Organization Report 2023, an estimated global total of 10.6 million people (ranging from 9.9 to 11.4 million) contracted TB, translating to 133 incident cases per 100,000 individuals. The majority of TB cases in 2022 were concentrated in the WHO regions of Southeast Asia (46%), Africa (23%), and the Western Pacific (18%), with smaller proportions in the Eastern Mediterranean (8.1%), the Americas (3.1%), and Europe (2.2%) in 2022. While TB primarily affects the lungs, it can also spread to other parts of the body (extrapulmonary TB). EBUS can be a valuable tool in diagnosing extrapulmonary TB cases by guiding needle biopsies of lymph nodes or other affected tissues. The number of tuberculosis (TB) cases is expected to rise, further fueling the demand for endobronchial ultrasound biopsy for this specific region.

Therefore, owing to the aforementioned factors, such as the high burden of respiratory diseases and increasing demand for minimally invasive procedures, the market is anticipated to witness growth during the forecast period. However, the high cost of equipment and lack of reimbursement policies in developing countries are likely to restrain the market's growth.

Endobronchial Ultrasound Biopsy Industry Overview

The endobronchial ultrasound biopsy market is fragmented in nature due to the presence of several global and local market players. Some key market players are Medtronic, Boston Scientific Corporation, CONMED Corporation, Olympus Corporation, Cook Group, ENDO-FLEX GmbH, CLINODEVICE, Medi-Globe GmbH, and Micro-Tech Endoscopy. Competition will likely intensify as established players refine their technologies and new entrants bring innovative solutions. Advancements in AI, fusion imaging, and cost-effective solutions are expected to drive the market's growth.

Endobronchial Ultrasound Biopsy Market Leaders

  1. Boston Scientific Corporation

  2. CONMED Corporation

  3. Olympus Corporation

  4. Medtronic

  5. Cook Group

  6. *Disclaimer: Major Players sorted in no particular order
Endobronchial Ultrasound Biopsy Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Endobronchial Ultrasound Biopsy Market News

  • September 2023: Roncus Medical launched the BioStar Transbronchial Aspiration Needle (TBNA). This innovative needle is designed for minimally invasive lung tissue acquisition during EBUS procedures, aiding in the diagnosis and staging of lung cancer.
  • February 2023: TransMed launched Concorde US ultrasound-guided soft-tissue biopsy devices that have been used in a series of clinical cases.

Endobronchial Ultrasound Biopsy Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population
    • 4.2.2 Increasing Prevalence of Respiratory Disorders
    • 4.2.3 Increasing demand for Minimally Invasive Procedures
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Equipment
    • 4.3.2 Lack Reimbursement Policies in Developing Countries
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product
    • 5.1.1 Biopsy Forceps
    • 5.1.2 Cytology Brushes
    • 5.1.3 Biopsy Needles
    • 5.1.4 Transbronchial Aspiration Needles
    • 5.1.5 Spray Catheters
    • 5.1.6 Other Products
  • 5.2 By Application
    • 5.2.1 Cancer Diagnosis
    • 5.2.2 Infection Diagnosis
    • 5.2.3 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 ACE Medical Devices Pvt. Ltd
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 CLINODEVICE
    • 6.1.4 CONMED Corporation
    • 6.1.5 Cook Group
    • 6.1.6 ENDO-FLEX GmbH
    • 6.1.7 Medi-Globe GmbH
    • 6.1.8 Medtronic
    • 6.1.9 Micro-Tech Endoscopy
    • 6.1.10 Olympus Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Endobronchial Ultrasound Biopsy Industry Segmentation

As per the scope of the report, endobronchial ultrasound is a technique for biopsy and visualization of the structure around the tracheobronchial tree.

The endobronchial ultrasound biopsy market is segmented by product, application, and geography. By product, the market is segmented into biopsy forceps, cytology brushes, biopsy needles, transbronchial aspiration needles, spray catheters, and other products. By application, the market is segmented into cancer diagnosis, infection diagnosis, and other applications. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report offers the value (USD) for the above segments.

By Product Biopsy Forceps
Cytology Brushes
Biopsy Needles
Transbronchial Aspiration Needles
Spray Catheters
Other Products
By Application Cancer Diagnosis
Infection Diagnosis
Other Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Endobronchial Ultrasound Biopsy Market Research FAQs

What is the current Endobronchial Ultrasound Biopsy Market size?

The Endobronchial Ultrasound Biopsy Market is projected to register a CAGR of 4.36% during the forecast period (2025-2030)

Who are the key players in Endobronchial Ultrasound Biopsy Market?

Boston Scientific Corporation, CONMED Corporation, Olympus Corporation, Medtronic and Cook Group are the major companies operating in the Endobronchial Ultrasound Biopsy Market.

Which is the fastest growing region in Endobronchial Ultrasound Biopsy Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Endobronchial Ultrasound Biopsy Market?

In 2025, the North America accounts for the largest market share in Endobronchial Ultrasound Biopsy Market.

What years does this Endobronchial Ultrasound Biopsy Market cover?

The report covers the Endobronchial Ultrasound Biopsy Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Endobronchial Ultrasound Biopsy Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Endobronchial Ultrasound Biopsy Industry Report

Statistics for the 2025 Endobronchial Ultrasound Biopsy market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Endobronchial Ultrasound Biopsy analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.